A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Efficacy and Safety Study of Tezepelumab in Patients with Eosinophilic Esophagitis (CROSSING)

Project: Research

Project Details

StatusFinished
Effective start/end date4/04/23 → 3/04/25

Keywords

  • Clinical trial
  • CROSSING
  • Eosinophilic Esophagitis

Clinical Trial Phase

  • Phase III (a & b)